New findings show that the stage of normal cell development at which B cells transform into leukemic cells affects treatment outcomes for paediatric...
Vous n'êtes pas connecté
- ONCOLOGYNEWS.COM.AU - A La Une - 17/08/2024 14:16
Improved chemokine homing enhances CAR T–cell therapy for osteosarcoma
Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells. While successful in some types of leukaemia, the approach has yet to realise its potential against paediatric solid tumours. Scientists at St. Jude Children’s Research Hospital have identified a way to improve CAR T–cell homing – a T cell’s ability [...]
Articles similaires
Institute enhances immunotherapy for difficult-to-treat brain tumours with gut microbiota
oncologynews.com.au - 06/Jul 22:04
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Institute enhances immunotherapy for difficult-to-treat brain tumours with gut microbiota
oncologynews.com.au - 08/Jul 14:35
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Institute enhances immunotherapy for difficult-to-treat brain tumours with gut microbiota
oncologynews.com.au - 08/Jul 14:35
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
New insights into natural killer cell brakes point to more effective combination cancer therapies
oncologynews.com.au - 08/Jul 15:12
A new comprehensive review reveals that harnessing natural killer (NK) cells by blocking their “off-switches” could significantly enhance cancer...
New insights into natural killer cell brakes point to more effective combination cancer therapies
oncologynews.com.au - 08/Jul 15:12
A new comprehensive review reveals that harnessing natural killer (NK) cells by blocking their “off-switches” could significantly enhance cancer...
Autologous Cell Therapy Product Market: Innovations, Growth Outlook, and Regional Focus on North America
wn.com - 15/Jul 07:22
Overview of Autologous Cell Therapy Product Market Global Cell Therapy Market is valued at USD 10.1 Billion in 2025 and is projected to attain a value...
Autologous Cell Therapy Product Market: Innovations, Growth Outlook, and Regional Focus on North America
wn.com - 15/Jul 07:22
Overview of Autologous Cell Therapy Product Market Global Cell Therapy Market is valued at USD 10.1 Billion in 2025 and is projected to attain a value...
Scientists identify key role of T-bet in flu memory B cells
news.medical.net - 12/Jul 02:42
At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the immune system, and immune...
New monoclonal antibody enhances immune response by selectively targeting Tregs
news.medical.net - 17/Jul 05:06
A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled "A novel anti-human CD25 mAb with preferential reactivity to...
Les derniers communiqués
-
Aucun élément